189 related articles for article (PubMed ID: 21062502)
1. Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study.
Wang R; Zou D; Ma X; Zhao Y; Yan X; Yan H; Fang J; Yin P; Kang X; Li Q; Dent J; Sung JJ; Halling K; Johansson S; Liu W; He J
Health Qual Life Outcomes; 2010 Nov; 8():128. PubMed ID: 21062502
[TBL] [Abstract][Full Text] [Related]
2. Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease.
Lee SW; Lien HC; Lee TY; Yang SS; Yeh HJ; Chang CS
World J Gastroenterol; 2014 Sep; 20(34):12277-82. PubMed ID: 25232262
[TBL] [Abstract][Full Text] [Related]
3. Burden of gastroesophageal reflux disease in Shanghai, China.
Wang R; Yan X; Ma XQ; Cao Y; Wallander MA; Johansson S; He J
Dig Liver Dis; 2009 Feb; 41(2):110-5. PubMed ID: 18706874
[TBL] [Abstract][Full Text] [Related]
4. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China.
He J; Ma X; Zhao Y; Wang R; Yan X; Yan H; Yin P; Kang X; Fang J; Hao Y; Li Q; Dent J; Sung JJ; Zou D; Wallander MA; Johansson S; Liu W; Li Z
BMC Gastroenterol; 2010 Aug; 10():94. PubMed ID: 20707933
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
Eloubeidi MA; Provenzale D
Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC).
Zou D; He J; Ma X; Chen J; Gong Y; Man X; Gao L; Wang R; Zhao Y; Yan X; Liu W; Wernersson B; Johansson S; Dent J; Sung JJ; Li Z
Scand J Gastroenterol; 2011 Feb; 46(2):133-41. PubMed ID: 20955088
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
[TBL] [Abstract][Full Text] [Related]
8. Use of the Montreal global definition as an assessment of quality of life in reflux disease.
Sawaya RA; Macgill A; Parkman HP; Friedenberg FK
Dis Esophagus; 2012 Aug; 25(6):477-83. PubMed ID: 21966890
[TBL] [Abstract][Full Text] [Related]
9. Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptoms.
Isshi K; Furuhashi H; Koizumi A; Nakada K
Esophagus; 2021 Jul; 18(3):684-692. PubMed ID: 33389239
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China.
Chen M; Xiong L; Chen H; Xu A; He L; Hu P
Scand J Gastroenterol; 2005 Jul; 40(7):759-67. PubMed ID: 16118911
[TBL] [Abstract][Full Text] [Related]
11. Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
Wahlqvist P; Carlsson J; Stålhammar NO; Wiklund I
Value Health; 2002; 5(2):106-13. PubMed ID: 11918826
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease.
Lippmann QK; Crockett SD; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2009 Nov; 104(11):2695-703. PubMed ID: 19755967
[TBL] [Abstract][Full Text] [Related]
13. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life.
Wahlqvist P
Am J Gastroenterol; 2001 Aug; 96(8 Suppl):S57-61. PubMed ID: 11510773
[TBL] [Abstract][Full Text] [Related]
14. Correlation of quality of life with gastroesophageal reflux disease amongst Qashqai nomads in Iran.
Masoumi SJ; Khademolhosseini F; Mehrabani D; Moradi F; Mostaghni AA; Zare N; Montazeri A; Saberi-Firoozi M
Arch Iran Med; 2012 Dec; 15(12):747-50. PubMed ID: 23199245
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.
Revicki DA; Wood M; Wiklund I; Crawley J
Qual Life Res; 1998 Jan; 7(1):75-83. PubMed ID: 9481153
[TBL] [Abstract][Full Text] [Related]
16. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease.
Velanovich V
J Gastrointest Surg; 1998; 2(2):141-5. PubMed ID: 9834409
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
Monroy M; Ruiz MA; Rejas J; Soto J
Health Qual Life Outcomes; 2018 Sep; 16(1):177. PubMed ID: 30200982
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
[TBL] [Abstract][Full Text] [Related]
19. [The risk factors and impact of gastroesophageal reflux disease on quality of life in general population].
Chen HX; Xiong LS; Xu AG; He LJ; Hu PJ; Chen MH
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):202-5. PubMed ID: 16624151
[TBL] [Abstract][Full Text] [Related]
20. Validation of a survey methodology for gastroesophageal reflux disease in China.
Cao Y; Yan X; Ma XQ; Wang R; Johansson S; Wallander MA; He J
BMC Gastroenterol; 2008 Aug; 8():37. PubMed ID: 18717991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
